Clinical trial · Observational
Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy
Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy : Assessment of Possible Complications and Histopathological Tumor Protein 53 (p53)-Signatures
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this prospective study, patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy were included. The aim of this study is to assess the prevalence of tubal histopathological abnormalities such as Serous Tubal Intraepithelial Carcinoma (STIC) and tumor protein 53 (p53) signatures) as well as the prevalence of perioperative and postoperative complications related to opportunistic laparoscopic salpingectomy in a low risk population. The hypothesis is that prophylactic salpingectomy during benign laparoscopic hysterectomy is both feasible and innocuous. Peri- and postoperative complications, duration of salpingectomy and post-salpingectomy blood loss, histopathological and immunohistochemical analysis with anti-p53 antibody were evaluated.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Benign Laparoscopic Hysterectomy | — | UNRESOLVED | — |
| Systematic Salpingectomy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Histopathologic tube anomalies | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Benign laparoscopic hysterectomy
- description
- Patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy
- interventionNames
- Other: Histopathologic tube anomalies
Primary outcomes (1)
- measure
- Histopathologic tube anomalies
- timeFrame
- day 1 of surgery
- description
- Prevalence of histopathologic tube anomalies (Serous Tubal Intraepithelial Carcinoma STIC or tumor protein 53 (p53) lesion)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy Exclusion Criteria: * Hysterectomy in a context of gynecologic cancer * Hysterectomy not carried out using laparoscopy * Fimbriated end missing or damaged or impossible for pathologist to analyze
References
Publications (0)
Data not yet available